Human chromogranin A ELISA kit can be used for specifically detecting in vitro quantitative concentrations of chromogranin A (ChgA, parathyroid secretory protein 1) human serum and plasma. This assay has a minimum sensitivity detection limit of 1.4 ng/ml.
Chromogranin A (ChgA) is also called parathyroid secretory protein 1, consists of 439 amino acids that is a 49 kDa acidic protein encoded on chromosome 14. It belongs to the member of granin family of neuroendocrine secretory proteins and has been identified in a large number of normal and neoplastic endocrine tissues. This chromogranin A ELISA kit is only suitable for either plasma or serum sample analysis. Examples of cells that are producing chromogranin A include chromaffin cells of the medulla, adrenal, enterochromaffin-like, paraganglia and beta cells of the pancreas. They are present in the islet beta cell secretory granules. It is a precursor to several functional peptides such as pancreastatin, vasostatin-1, vasostatin-2, parastatin and catestatin, all of these peptides have the ability to negatively modulate the neuroendocrine function nearby cells (paracrine response) or releasing cell (autocrine response). Chromogranin A (ChgA) has the ability to induce and promote the generation of secretory granules such as those containing insulin within pancreatic islet beta cells.
This assay is ideal for measuring various types of diagnostic applications. There have been evidence to suggest that elevated circulating chromogranin A levels would be vital markers for tumors of neuroendocrine origin. However, recently, one of the most significant clinical use of chromogranin A has been related to the diagnostic procedure in patients of pheochromocytoma. It was found that the drugs that were often used to treat and diagnose pheochromocytoma had very little effect on the plasma concentrations of chromogranin A. This finding meant that measuring chromogranin A instead of catecholamines would offer greater advantages. It therefore provides a very sensitive and highly specific marker in the evaluation of suspected or actual pheochromocytoma patients.
CHROMOGRANIN A ELISA KIT CONTENT
All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.
- Microtiter Plate – Coated with human chromogranin A antibody.
- Standard A-E (Lyophilized) – Concentrations 0, 50, 150, 500, 1500 µg/l.
- Control 1 And Control 2 (Lyophilized).
- Adjustment Buffer.
- Wash Buffer Concentrated.
- Substrate Solution – Tetramethylbenzidine (TMB).
- Stop Solution.
The minimum sensitivity detection limit of ChgA (chromogranin A, parathyroid secretory protein 1) using current human chromogranin A ELISA kit was approximately 1.4 ng/ml. The dynamic range for this assay is 0 – 2,500 ng/ml.
– Chromogranin A (ChgA): ELISA
– Expected Reference Values: < 100 µg/l
– Analytical Sensitivity (Limit of Detection): 10 µg/l.
– Linearity: r = 0985.
– Recovery: 106.1 %.
– Precision Intra-Assay: 8.9 %.
– Precision Inter-Assay: 9.5 %
– High-Dose Hook Effect: No high-dose hook effect up to 2 000 000 µg/l.
- A Critical Approach to Clinical Biochemistry of Chromogranin A. Adv Exp Med Biol. (2015) 867: 317-23. Review. Bottoni P., et al.
- Chromogranin A: any relevance in neuroendocrine tumors? Curr Opin Endocrinol Diabetes Obes. (2016) 23 (1): 28-37. Review. Kidd M., et al.
- The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions. Cardiovasc Res. (2010) 85 (1): 9-16. Review. Helle K.B.
- The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. (2011) 40 (1): 111-34, viii. Review. Lawrence B., et al.
- New biological aspects of chromogranin A-derived peptides: focus on vasostatins. Comp Biochem Physiol A Mol Integr Physiol. (2007) 147 (1): 11-8. Review. Tota B., et al.
- Full Name: Chromogranin A ELISA Kit
- Reactivity: Human
- Sample Type: Serum, Plasma
- Sensitivity: 1.4 ng/ml